As an academic medical center, research is core to Stony Brook's mission because it helps to advance the practice of medicine and raises the standard of care in the community.
Pediatric cancer patients at Stony Brook have the advantage of access to a wide range of research and clinical studies, many of which are promising new treatments that one day may be the standard of care. All eligible patients are invited to participate in appropriate clinical trials, but there is no obligation that they do so.
Because it is so important to continue improving therapies and developing new treatments for cancer and blood disorders, ongoing research is a priority at the Department of Hematology/Oncology. As a full member of the Children's Oncology Group, Stony Brook physicians have access to the most current cutting-edge cancer treatment clinical protocols that explore treatments to increase cure and reduce unwanted late effects of cancer treatment. We collaborate with other researchers at Stony Brook University Cancer Center on research pertinent to childhood cancers, and adolescent and young adulty (AYA) cancers. In addition, we participate in a variety of clinical trials initiated by Pharmaceutical companies. Ongoing institutional research currently focuses on obesity after cancer therapy, neurocognitive outcomes after cancer therapy, best practices in Pediatric Palliative Care, and mucositis/oral health in oncology patients.
By facilitating medical education, Stony Brook remains on the leading edge of medicine, continually invigorating its program with fresh viewpoints, a lively exchange of ideas, and the region's next generation of top doctors. Currently both medical students and pediatric residents participate in rotations through the department.